» Authors » Michael Hurst

Michael Hurst

Explore the profile of Michael Hurst including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 13
Citations 63
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Hurst M, Shin L
Semin Vasc Surg . 2025 Mar; 38(1):74-84. PMID: 40086925
Charcot neuroarthropathy (CN) is an inflammatory condition affecting the joints of patients with peripheral neuropathy; its prevalence is as high as 7.5%. It is commonly seen in patients with diabetes...
2.
Osman F, Zema C, Hurst M, Sandler B, Brellier F, Utuama O, et al.
ESC Heart Fail . 2025 Feb; PMID: 39943699
Aims: Describe patient characteristics, treatment patterns, clinical outcomes, healthcare resource utilization (HCRU) and medical costs associated with patients who were diagnosed with obstructive hypertrophic cardiomyopathy (HCM) in clinical practice in...
3.
Hurst M, Zema C, Krause T, Sandler B, Lemmer T, Noon K, et al.
BMJ Open . 2025 Jan; 14(12):e080142. PMID: 39806583
Objective: To estimate the resource use of patients with obstructive hypertrophic cardiomyopathy (HCM), stratified by New York Heart Association (NYHA) class, in the English and Northern Irish healthcare systems via...
4.
Pollock K, Dickerson C, Kainth M, Lawton S, Hurst M, Sugrue D, et al.
BMC Prim Care . 2024 Jan; 25(1):7. PMID: 38166641
Background: Conducting effective and translational research can be challenging and few trials undertake formal reflection exercises and disseminate learnings from them. Following completion of our multicentre randomised controlled trial, which...
5.
Marshall A, Meyer C, Hurst M, Hughes H, Burns P
J Foot Ankle Surg . 2023 Sep; 63(1):114-118. PMID: 37717848
Charcot neuroarthropathy's (CN) anatomic classification was originally formulated by the Brodsky article and the Trepman et al modification, including midfoot (type 1), rearfoot (type 2), ankle (type 3a), calcaneus (type...
6.
Hill N, Groves L, Dickerson C, Ochs A, Pang D, Lawton S, et al.
Eur Heart J Digit Health . 2023 Jan; 3(2):195-204. PMID: 36713002
Aims: The aim of the PULsE-AI trial was to assess the effectiveness of a machine learning risk-prediction algorithm in conjunction with diagnostic testing for identifying undiagnosed atrial fibrillation (AF) in...
7.
Hill N, Groves L, Dickerson C, Boyce R, Lawton S, Hurst M, et al.
J Med Econ . 2022 Jul; 25(1):974-983. PMID: 35834373
Objective: The PULsE-AI trial sought to determine the effectiveness of a screening strategy that included a machine learning risk prediction algorithm in conjunction with diagnostic testing for identification of undiagnosed...
8.
Choy E, Groves L, Sugrue D, Hurst M, Houghton J, Venkatachalam S, et al.
BMC Rheumatol . 2021 Feb; 5(1):3. PMID: 33536080
Background: Rheumatoid arthritis (RA) is an inflammatory autoimmune disease that causes chronic synovitis, resulting in progressive joint destruction and functional disability and affects approximately 400,000 people in the UK. This...
9.
Tafesse E, Hurst M, Hoskin L, Badora K, Sugrue D, Qin L, et al.
Int J Clin Pract . 2020 Dec; 75(4):e13941. PMID: 33332710
Introduction: Hyperkalaemia (HK) is associated with increased mortality risk. Prior studies suggest that the causes of HK are multifactorial. This study aimed to examine risk factors for incident and recurrent...
10.
Hill N, Arden C, Beresford-Hulme L, Camm A, Clifton D, Davies D, et al.
Contemp Clin Trials . 2020 Oct; 99:106191. PMID: 33091585
Atrial fibrillation (AF) is associated with an increased risk of stroke, enhanced stroke severity, and other comorbidities. However, AF is often asymptomatic, and frequently remains undiagnosed until complications occur. Current...